Press Release: July 11, 2020
VulcanChem (California, USA) and its collaborating facilities are providing research-grade compounds of potential drugs to help to accelerate the ongoing research to find a cure.
California, USA., July 1st 2020 -- Over 10 million people worldwide have tested positive for the novel coronavirus and that number is quickly growing. The healthcare system is becoming increasingly strained and the world are in desperate need of a safe and effective treatment for COVID-19. Scientists around the world are racing against time to find a cure/drug. VulcanChem (California, USA) and its collaborating facilities are providing research-grade compounds of potential drugs to help to accelerate the ongoing research to find a cure.
Please note that the following items are for research use only. Not for human or veterinary use.
Remdesivir is an antiviral that is given by intravenous (IV) infusion in the hospital. This is a brand-new drug that has not been approved by the FDA for use on the market yet, and is being tested in carefully controlled environments. It was previously shown to have some effect against SARS, MERS, and Ebola in cell and animal models. In a recent in vitro study (studies done in a petri dish or test tube rather than in animals or humans), remdesivir prevented human cells from being infected with SARS-CoV-2 (the virus that causes COVID-19).
For more information: https://www.vulcanchem.com/product/inhibitors/VC1031201
Dexamethasone is a common corticosteroid (steroid) medication that has been used for many years to treat various health conditions, such as autoimmune conditions and allergic reactions. RECOVERY, a randomized clinical trial in the UK, is studying many medications, including dexamethasone, to see if any are effective against COVID-19.
For more information: https://www.vulcanchem.com/product/inhibitors/VC1051515
3) Hydroxychloroquine and chloroquine
Hydroxychloroquine and chloroquine are two medications that have been used for many decades to treat malaria and autoimmune conditions like rheumatoid arthritis and lupus. A few small studies suggest that they may also be helpful for treating hospitalized patients with mild cases of COVID-19, while many other studies showed that hydroxychloroquine did not make a difference. More robust studies are needed to confirm whether these medications actually work.
`For more information: https://www.vulcanchem.com/product/inhibitors/VC1031211
Azithromycin (informally known as a Z-pak) is an antibiotic commonly used to treat bacterial infections such as bronchitis and pneumonia. It has been shown to have some in vitro activity against viruses like influenza A and Zika, but did not work against the coronavirus that causes MERS.
For more information: https://www.vulcanchem.com/product/inhibitors/VC1040653
5) Avigan (favipiravir)
Favipiravir (also known as Avigan) is an antiviral medication approved in Japan and China for the flu. In vitro studies have shown that high doses of favipiravir were able to prevent human cells from being infected with SARS-CoV-2.
For more information: https://www.vulcanchem.com/product/inhibitors/259793-96-9
6) Colcrys (colchicine)
Colchicine is a medication used for gout. It works in many different ways, including activating anti-inflammatory processes and interfering with cells involved in inflammation. Researchers think that colchicine could work similarly to Actemra in COVID-19 patients in that it might be helpful if the immune system becomes too activated and a cytokine storm occurs. A large clinical trial is currently seeing if colchicine, when given soon after a COVID-19 diagnosis, can lower the chances of hospitalization and death.
For more information: https://www.vulcanchem.com/product/inhibitors/VC1048349
Ivermectin is an oral medication used to treat infections caused by parasites. It is also available as a lotion or cream to treat lice and rosacea. A recent in vitro study found that ivermectin can stop SARS-CoV-2 from replicating. A lot more research is needed to see if the doses studied would be safe and effective against the virus in humans.
For more information: https://www.vulcanchem.com/product/inhibitors/VC1062099
8) Tamiflu (oseltamivir)
Tamiflu is an antiviral medication used for influenza (flu). Results from a hospital in Wuhan, China were not promising. Of 138 hospitalized patients, 124 got Tamiflu along with other medications. By the end of the study, 85 patients (62%) were still hospitalized and 6 had died. Nonetheless, several clinical trials are currently looking at Tamiflu in combination with other medications for coronavirus.
For more information: https://www.vulcanchem.com/product/reference-standards/196618-13-0
There is no cure or vaccine for COVID-19 at this time. More studies are needed to confirm if any of the potential treatments listed above will work for COVID-19. Research on COVID-19 is rapidly evolving. For now, the treatment for patients with mild symptoms is to self-isolate at home. Patients who are hospitalized receive supportive care (such as oxygen), enroll in clinical trials, and are given medications off-label based on hospital guidelines and their doctors’ clinical judgement.
Headquartered in California, USA, VulcanChem is a global leading manufacturer and supplier of specialty chemicals of high-quality including building blocks, novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. We now have representatives or branch offices on the East Coast of the US, and in Europe and Asia. Our clients include academic, industrial and government research and development laboratories as well as commercial scale businesses in the pharmaceutical and chemical industries.
680 East Colorado Boulevard
Pasadena CA 91101 USA